Skip to search.
 TSX Down 0.62% TSX Ventures Down 0.53%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
0.91 Down 0.06(6.66%) May 2, 4:00PM EDT
Prev Close:0.98
Open:0.96
Bid:0.83 x 3000
Ask:1.20 x 5900
1y Target Est:2.15
Beta:1.94187
Next Earnings Date:12-May-16OGXI Earnings announcement
Day's Range:0.91 - 0.98
52wk Range:0.46 - 4.10
Volume:294,040
Avg Vol (3m):431,627
Market Cap:27.26M
P/E (ttm):N/A
EPS (ttm):-0.86
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OGXIDown 6.66%27.26M
CELGUp 1.51%82.05B
PFEUp 0.28%203.09B
BMYDown 0.30%120.12B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.94
Quarterly EPS Est (Mar-16) :-0.12
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback